AzTrials
AzTrials

Hypotension on InductionNCT06968091

Effect of Trendelenburg Positioning on Anesthesia-Induced Hypotension in Elderly Patients

A study testing Trendelenburg position and Supine Horizontal Position in people with Hypotension on Induction and Old Age, run by Zhejiang Cancer Hospital at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study investigated the effect of Trendelenburg position on preventing post-induction hypotension in elderly patients undergoing abdominal surgery with general anesthesia. The patients will receive the 10° Trendelenburg position or supine position during anesthesia induction. Read more about this study

Who is it for?
Ages 65 to 90 years
Conditions the study is for
Hypotension on Induction, Old Age
What is being tested?
Trendelenburg position and Supine Horizontal Position
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
168 participants
Where
1 siteChina
Study dates
16 May 2025to 3 Apr 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 to 90 years
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • patients aged 65-90 years
  • scheduled for abdominal surgery with general anesthesia
  • expected to have continuous radial arterial pressure monitoring
  • American Society of Anesthesiologists (ASA) physical status I to III

Who cannot join

  • contraindications or failure of radial arterial catheterization
  • expected possible difficult airway
  • non-sinus rhythm
  • increased intracranial pressure
  • patients at high risk of regurgitation or aspiration
  • inability to provide consent

Trial locations and contacts

1 site in 1 country.

China1 site
  • Zhejiang cancer hospital

    Hangzhou, Zhejiang

Other trials in China

About this study

Official title: Effect of Trendelenburg Positioning on Anesthesia-Induced Hypotension in Elderly Patients: A Randomized Controlled Clinical Trial

This study investigated the effect of Trendelenburg position on preventing post-induction hypotension in elderly patients undergoing abdominal surgery with general anesthesia. The patients will receive the 10° Trendelenburg position or supine position during anesthesia induction. The primary outcome is the area under a mean arterial pressure (MAP) below 65 mm Hg within the first 15 minutes during anesthesia induction.

Being tested
Trendelenburg position, Supine Horizontal Position

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Trendelenburg positionOther

    After the loss of consciousness during general anesthesia, the 10° Trendelenburg position is adopted.

  • Supine Horizontal PositionOther

    After the loss of consciousness during general anesthesia, the Supine Horizontal Position is adopted.

Study groups in NCT06968091
Study groupRoleWhat they receive
The Trendelenburg Position GroupExperimentalNot described
Receives: Other: Trendelenburg position
The Supine Horizontal Position GroupPlacebo comparatorNot described
Receives: Other: Supine Horizontal Position

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The area under the curve of the mean arterial pressure being lower than 65 mmHg

    Measured: within 15 minutes after anesthesia induction

Secondary outcomes (27)
  1. The area under the curve of the mean arterial pressure being lower than 60 mmHg

    Measured: within 15 minutes after anesthesia induction

  2. The area under the curve of the mean arterial pressure being lower than 50 mmHg

    Measured: within 15 minutes after anesthesia induction

  3. The area under the curve of the mean arterial pressure being lower than 40 mmHg

    Measured: within 15 minutes after anesthesia induction

  4. The duration during which the Mean Arterial Pressure (MAP) is less than 65 mmHg

    Measured: within 15 minutes after anesthesia induction

  5. The duration during which the Mean Arterial Pressure (MAP) is less than 60 mmHg

    Measured: within 15 minutes after anesthesia induction

  6. The duration during which the Mean Arterial Pressure (MAP) is less than 50 mmHg

    Measured: within 15 minutes after anesthesia induction

  7. The duration during which the Mean Arterial Pressure (MAP) is less than 40 mmHg

    Measured: within 15 minutes after anesthesia induction

  8. The usage of vasoactive drugs

    The vasoactive drugs are selected from the following according to the protocol: phenylephrine, ephedrine, norepinephrine, and epinephrine.

    Measured: within 15 minutes after anesthesia induction and during the whole process of the surgery

  9. The lowest mean arterial pressure

    Measured: within 15 minutes after anesthesia induction

  10. the postoperative complications

    The complications are assessed using the Claviene-Dindo score.

    Measured: within 30 days after surgery

  11. the postoperative recovery

    The postoperative recovery is assessed using the quality of recovery-15 questionnaire (QoR-15) .The QoR-15 has 15 questions. Each question is rated on a 10-point scale, ranging from 0 (none of the time or poor) to 10 (all of the time or excellent). The maximum score (best recovery) is 150.

    Measured: on postoperative day 1

  12. Length of hospital stay after surgery

    Measured: through study completion, an average of 3-15 days

  13. The time duration required to complete endotracheal intubation

    Measured: through study completion, an average of 10-60 s

  14. The incidence of refractory hypotension

    If either of the following two definitions is met, it is considered refractory hypotension:

    1. During the anesthesia induction period, the total administered dosage exceeds the maximum dose, and the patient's hypotension does not recover. The maximum usage dose of ephedrine is 0.5 mg/kg (ideal body weight), and the maximum usage dose of phenylephrine is 8 μg/kg (ideal body weight).
    2. When two or more vasoactive drugs are used, the systolic blood pressure is less than 80 mmHg or the mean blood pressure is less than 65 mmHg continuously for more than 5 minutes.

    Measured: within 15 minutes after anesthesia induction

  15. The number of attempts at tracheal intubation

    Measured: through study completion, an average of 1-2times

  16. The dosage of propofol during the anesthesia induction period

    Measured: within 15 minutes after anesthesia induction

  17. The dosage of remifentanil during the anesthesia induction period

    Measured: within 15 minutes after anesthesia induction

  18. The VIDIAC score of the video laryngoscope.

    The VIDIAC score is comprised of: E, the interaction between the blade tip and epiglottis; V, the best view of the vocal cords from the blade camera; and A, enlargement of the arytenoids. The score range of the VIDIAC score is from -1 to 5 points. The VIDIAC score classification is as follows: Easy, with a score of -1 or 0; Moderate, with a score of 1; Difficult, with a score of 2; Severe, with a score of ≥3.

    Measured: through study completion, an average of -1~1 points

  19. The usage of other medications during the anesthesia induction period

    The usage of medications other than propofol, remifentanil, phenylephrine, ephedrine, norepinephrine, and epinephrine.

    Measured: within 15 minutes after anesthesia induction

  20. The area under the curve of the mean arterial pressure being lower than 65 mmHg

    Measured: within 20 minutes after anesthesia induction

  21. The pulse pressure variation rate after mechanical ventilation.

    Measured: At the 1st, 3rd, 5th and 10th minutes after tracheal intubation

  22. The peak airway pressure after mechanical ventilation.

    Measured: At the 1st minutes after tracheal intubation

  23. The infusion volume of crystalloid solution during the induction period.

    Measured: within 15 minutes after anesthesia induction

  24. Arterial systolic pressure after anesthesia induction

    The monitor records continuous arterial blood pressure data at intervals of 1 second.

    Measured: At the 1st, 2nd, 3rd, 4th, 5th, 6th, 7th, 8th, 9th, 10th, 11th, 12th, 13th, 14th, 15th, 16th, 17th, 18th, 19th and 20th minutes after anesthesia induction.

  25. Arterial diastolic pressure after anesthesia induction

    The monitor records continuous arterial blood pressure data at intervals of 1 second.

    Measured: At the 1st, 2nd, 3rd, 4th, 5th, 6th, 7th, 8th, 9th, 10th, 11th, 12th, 13th, 14th, 15th, 16th, 17th, 18th, 19th and 20th minutes after anesthesia induction.

  26. Mean arterial pressure after anesthesia induction

    The monitor records continuous arterial blood pressure data at intervals of 1 second.

    Measured: At the 1st, 2nd, 3rd, 4th, 5th, 6th, 7th, 8th, 9th, 10th, 11th, 12th, 13th, 14th, 15th, 16th, 17th, 18th, 19th and 20th minutes after anesthesia induction.

  27. Heart rate after anesthesia induction

    Measured: At the 1st, 2nd, 3rd, 4th, 5th, 6th, 7th, 8th, 9th, 10th, 11th, 12th, 13th, 14th, 15th, 16th, 17th, 18th, 19th and 20th minutes after anesthesia induction.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 May 2025
  2. Study start16 May 2025
  3. Primary completion1 Apr 2026
  4. Study completion3 Apr 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
168 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06968091
Sponsor's protocol ID
IRB-2025-478
Status last verified
Apr 2026
First submitted
3 May 2025
Last updated
9 Apr 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: We will share data on ClinicalTrials.gov, and data sharing will be always available.

Questions about this trial

What is this clinical trial studying?

A study testing Trendelenburg position and Supine Horizontal Position in people with Hypotension on Induction and Old Age, run by Zhejiang Cancer Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The area under the curve of the mean arterial pressure being lower than 65 mmHg (time frame: within 15 minutes after anesthesia induction). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in